CV Prof. Martine Piccart

Martine Piccart

Jules Bordet Institute, Brussels, Belgium

Professor Martine J. Piccart, M.D., Ph.D., is honorary professor of oncology at the Université Libre de Bruxelles (ULB) and scientific director at the Jules Bordet Institute (Brussels/Belgium). Earning her medical degrees at ULB and oncology qualifications in New York and London, she is also a member of the Belgian Royal Academy of Medicine. She held presidencies of the European CanCer Organisation (ECCO), the European Organisation for the Research and Treatment of Cancer (EORTC), the European Society for Medical Oncology (ESMO) and served on the American Society of Clinical Oncology Board (ASCO). Presently she is a member of the Board of the American Association for Cancer Research (AACR) which nominated her as fellow of the AACR Academy in 2013. 

A strong advocate for and leader of international research collaborations, Professor Piccart, together with professor Aron Goldhirsch, created the Breast International Group (BIG) in 1996 to foster collaboration and accelerate the development of better breast cancer treatments. The organisation, chaired by professor Piccart, became an international not-for-profit organization in 1999, and today unites 59 academic breast cancer research groups from around the world. BIG successfully managed high-profile phase 3 clinical trials that changed clinical practice: HERA (Herceptin Adjuvant), MINDACT (Microarray in Node negative/1-3 positive lymph node disease may avoid chemotherapy) and APHINITY (Adjuvant trastuzumab + pertuzumab superior to trastuzumab alone).

Throughout her career, professor Piccart has been honoured with numerous prestigious awards for her research contributions, including the Jill Rose Award (2009, USA), the William L. McQuire Award (2009, USA), the David A. Karnofsky Memorial Award (2013, USA), the Susan G. Komen’s Brinker Award for Scientific Distinction (2015, USA), the 2017 St. Gallen International Breast Cancer Award (Vienna) and most recently, the 2018 Prix Leopold Griffuel for translational and clinical research delivered by the “Association pour la Recherche sur le Cancer” in France.

An accomplished clinician and scientist, professor Piccart is author or co-author of over 500 publications in peer-reviewed journals.

The scientific contributions of Martine Piccart to the progress of the treatment of breast cancer have uniquely impacted on clinical practice. A countless number of women with breast cancer on this globe have benefited from the therapeutic advances that emerged from her research,” according to jury chairman Bob Löwenberg, professor of Hematology at Erasmus University Rotterdam.

See also this review and youtube link